LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION March 30, 2009 TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:SB1127 by Van de Putte (Relating to the confidentiality of test results of samples of compounded products.), As Introduced No fiscal implication to the State is anticipated. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:515 Board of Pharmacy LBB Staff: JOB, CL, ES
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 81ST LEGISLATIVE REGULAR SESSION
March 30, 2009
TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services FROM: John S. O'Brien, Director, Legislative Budget Board IN RE:SB1127 by Van de Putte (Relating to the confidentiality of test results of samples of compounded products.), As Introduced
TO: Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
FROM: John S. O'Brien, Director, Legislative Budget Board
IN RE: SB1127 by Van de Putte (Relating to the confidentiality of test results of samples of compounded products.), As Introduced
Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
Honorable Jane Nelson, Chair, Senate Committee on Health & Human Services
John S. O'Brien, Director, Legislative Budget Board
John S. O'Brien, Director, Legislative Budget Board
SB1127 by Van de Putte (Relating to the confidentiality of test results of samples of compounded products.), As Introduced
SB1127 by Van de Putte (Relating to the confidentiality of test results of samples of compounded products.), As Introduced
No fiscal implication to the State is anticipated.
No fiscal implication to the State is anticipated.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 515 Board of Pharmacy
515 Board of Pharmacy
LBB Staff: JOB, CL, ES
JOB, CL, ES